Media headlines about Youngevity International (NASDAQ:YGYI) have been trending somewhat positive recently, Accern reports. The research group scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Youngevity International earned a news impact score of 0.18 on Accern’s scale. Accern also gave headlines about the company an impact score of 45.1298586593095 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Separately, Benchmark started coverage on Youngevity International in a report on Friday. They issued a “buy” rating and a $7.00 price objective on the stock.
Youngevity International traded up $0.13, reaching $4.24, during trading hours on Friday, MarketBeat reports. 11,959 shares of the stock were exchanged, compared to its average volume of 20,124. The company has a debt-to-equity ratio of 1.56, a quick ratio of 0.33 and a current ratio of 0.92. Youngevity International has a twelve month low of $3.17 and a twelve month high of $6.75.
Youngevity International Company Profile
Youngevity International, Inc develops and distributes health and nutrition related products and services through independent direct selling network in the United States and internationally. It operates in two segments, Direct Selling and Commercial Coffee. The company offers approximately 5,500 products, including nutritional, vitamin, mineral, herbal, liquid, and dietary supplements; apparel; fashion and jewelry accessories; digital products; and packaged foods.
Read More: Stock Symbols Definition, Examples, Lookup
Receive News & Ratings for Youngevity International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Youngevity International and related companies with MarketBeat.com's FREE daily email newsletter.